Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gagne

Showing results (1-10 of 344) with videos related to

Pageof 35
Sort By:
Drug Safety|September 5, 2014
Restrictive reimbursement policies: bias implications for claims-based drug safety studiesJoshua J Gagne
Epidemiology (Cambridge, Mass.)|August 2, 2013
You can observe a lot (about medical products) by watching (those who use them)Joshua J Gagne
Drug Safety|June 20, 2015
Common Models, Different ApproachesJoshua J Gagne
JAMA Internal Medicine|October 21, 2014
Finding meaningful patterns in adverse drug event reportsJoshua J Gagne
Journal of Vascular Surgery|May 18, 2011
Invited commentaryPaul J Gagne
Pharmacoepidemiology and Drug Safety|February 22, 2017
New-user designs with conditional propensity scores: a unified complement to the traditional active comparator new-user approachJoshua J Gagne
Pharmacoepidemiology and Drug Safety|June 10, 2016
Balancing benefits and harms: privacy protection policiesAmeet Sarpatwari, Joshua J Gagne
Statistics in Medicine|February 16, 2013
Comment on 'empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership'Joshua J Gagne, Sebastian Schneeweiss
Journal of Clinical Pharmacy and Therapeutics|February 24, 2010
Impact of ALLHAT publication on antihypertensive prescribing patterns in Regione Emilia-Romagna, ItalyV Maio, J J Gagne
JAMA|July 5, 2022
Type of Oral Anticoagulant and Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for VTE-ReplyKatsiaryna Bykov, Joshua J Gagne
Pageof 35

Showing results (1-10 of 344) with videos related to

Sort By:
Pageof 35
Drug Safety|September 5, 2014
Restrictive reimbursement policies: bias implications for claims-based drug safety studiesJoshua J Gagne
Epidemiology (Cambridge, Mass.)|August 2, 2013
You can observe a lot (about medical products) by watching (those who use them)Joshua J Gagne
Drug Safety|June 20, 2015
Common Models, Different ApproachesJoshua J Gagne
JAMA Internal Medicine|October 21, 2014
Finding meaningful patterns in adverse drug event reportsJoshua J Gagne
Journal of Vascular Surgery|May 18, 2011
Invited commentaryPaul J Gagne
Pharmacoepidemiology and Drug Safety|February 22, 2017
New-user designs with conditional propensity scores: a unified complement to the traditional active comparator new-user approachJoshua J Gagne
Pharmacoepidemiology and Drug Safety|June 10, 2016
Balancing benefits and harms: privacy protection policiesAmeet Sarpatwari, Joshua J Gagne
Statistics in Medicine|February 16, 2013
Comment on 'empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership'Joshua J Gagne, Sebastian Schneeweiss
Journal of Clinical Pharmacy and Therapeutics|February 24, 2010
Impact of ALLHAT publication on antihypertensive prescribing patterns in Regione Emilia-Romagna, ItalyV Maio, J J Gagne
JAMA|July 5, 2022
Type of Oral Anticoagulant and Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for VTE-ReplyKatsiaryna Bykov, Joshua J Gagne
Pageof 35